| Cancer Type: Melanoma | |
| Description: A Randomized, Double-Blind, Phase 3 Trial of STA-4783 in Combination with Paclitaxel versus Paclitaxel Alone for Treatment of Chemotherapy-Na?ve Subjects with Stage IV Metastatic Melanoma (SYMMETRY) | |
| Entity Approving The Trial: Industry Sponsored |
|
| Phase: III | |
| Site-Wide Accrual Goal: 630 | |
| Related Files | |
| No related files found. | |
| Related Links | |
| No related links found. |